BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 19040468)

  • 1. Diagnostic value of CD163 in cutaneous spindle cell lesions.
    Pouryazdanparast P; Yu L; Cutlan JE; Olsen SH; Fullen DR; Ma L
    J Cutan Pathol; 2009 Aug; 36(8):859-64. PubMed ID: 19040468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical staining of CD10 in atypical fibroxanthomas.
    Hultgren TL; DiMaio DJ
    J Cutan Pathol; 2007 May; 34(5):415-9. PubMed ID: 17448198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD163 is not a sensitive marker for identification of atypical fibroxanthoma.
    Beer TW
    J Cutan Pathol; 2012 Jan; 39(1):29-32. PubMed ID: 22211334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of CD163 in dermatofibroma, cellular fibrous histiocytoma, and dermatofibrosarcoma protuberans: comparison with CD68, CD34, and Factor XIIIa.
    Sachdev R; Sundram U
    J Cutan Pathol; 2006 May; 33(5):353-60. PubMed ID: 16640542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical distinction of cutaneous spindle cell carcinoma.
    Morgan MB; Purohit C; Anglin TR
    Am J Dermatopathol; 2008 Jun; 30(3):228-32. PubMed ID: 18496422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p63 is a useful marker for cutaneous spindle cell squamous cell carcinoma.
    Dotto JE; Glusac EJ
    J Cutan Pathol; 2006 Jun; 33(6):413-7. PubMed ID: 16776716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of p63 in the differential diagnosis of atypical fibroxanthoma and spindle cell squamous cell carcinoma.
    Gleason BC; Calder KB; Cibull TL; Thomas AB; Billings SD; Morgan MB; Hiatt KM; Smoller BR
    J Cutan Pathol; 2009 May; 36(5):543-7. PubMed ID: 19476522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of CD10, wide-spectrum keratin, p63, and podoplanin in the distinction of epithelioid and spindle cell tumors of the skin: an immunohistochemical study of 81 cases.
    Buonaccorsi JN; Plaza JA
    Am J Dermatopathol; 2012 Jun; 34(4):404-11. PubMed ID: 22257901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD10, p63 and CD99 expression in the differential diagnosis of atypical fibroxanthoma, spindle cell squamous cell carcinoma and desmoplastic melanoma.
    Kanner WA; Brill LB; Patterson JW; Wick MR
    J Cutan Pathol; 2010 Jul; 37(7):744-50. PubMed ID: 20184665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of CD10 and procollagen 1 expression in atypical fibroxanthoma and dermatofibroma.
    de Feraudy S; Mar N; McCalmont TH
    Am J Surg Pathol; 2008 Aug; 32(8):1111-22. PubMed ID: 18545147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procollagen 1 and Melan-A expression in desmoplastic melanomas.
    Leinweber B; Hofmann-Wellenhof R; Kaddu S; McCalmont TH
    Am J Dermatopathol; 2009 Apr; 31(2):173-6. PubMed ID: 19318805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of S100A6 protein in a broad spectrum of cutaneous tumors using tissue microarrays.
    Fullen DR; Garrisi AJ; Sanders D; Thomas D
    J Cutan Pathol; 2008 Nov; 35 Suppl 2():28-34. PubMed ID: 18201235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD163 expression in leukemia cutis.
    Harms PW; Bandarchi B; Ma L
    J Cutan Pathol; 2010 Sep; 37(9):953-7. PubMed ID: 20175823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The utility of PU.1 as an immunohistochemical marker for histiocytic and dendritic lesions of the skin.
    Muirhead D; Stone MS; Syrbu SI
    Am J Dermatopathol; 2009 Jul; 31(5):432-5. PubMed ID: 19542915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of CD10 in distinguishing atypical fibroxanthoma from sarcomatoid (spindle cell) squamous cell carcinoma.
    Wieland CN; Dyck R; Weenig RH; Comfere NI
    J Cutan Pathol; 2011 Nov; 38(11):884-8. PubMed ID: 21883368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary cutaneous myxoid spindle cell squamous cell carcinoma: a clinicopathologic study and review of the literature.
    Yang A; Hanley A; Velazquez EF; Cassarino DS
    J Cutan Pathol; 2010 Apr; 37(4):465-74. PubMed ID: 19811587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of CD163 (hemoglobin scavenger receptor) in normal tissues, lymphomas, carcinomas, and sarcomas is largely restricted to the monocyte/macrophage lineage.
    Nguyen TT; Schwartz EJ; West RB; Warnke RA; Arber DA; Natkunam Y
    Am J Surg Pathol; 2005 May; 29(5):617-24. PubMed ID: 15832085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P75 nerve growth factor receptor as a useful marker to distinguish spindle cell melanoma from other spindle cell neoplasms of sun-damaged skin.
    Sigal AC; Keenan M; Lazova R
    Am J Dermatopathol; 2012 Apr; 34(2):145-50. PubMed ID: 22207443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AM-3K, an anti-macrophage antibody, recognizes CD163, a molecule associated with an anti-inflammatory macrophage phenotype.
    Komohara Y; Hirahara J; Horikawa T; Kawamura K; Kiyota E; Sakashita N; Araki N; Takeya M
    J Histochem Cytochem; 2006 Jul; 54(7):763-71. PubMed ID: 16517975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD10-positive myxofibrosarcomas: a pitfall in the differential diagnosis of atypical fibroxanthoma.
    Clarke LE; Frauenhoffer E; Fox E; Neves R; Bruggeman RD; Helm KF
    J Cutan Pathol; 2010 Jul; 37(7):737-43. PubMed ID: 20175824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.